Study of blood clot problems after COVID or flu
Part of Blood & lymphatic, Heart & circulation, Infections, Lungs & breathing clinical trials.
This study looks at blood clot–related complications after COVID-19 (and in some cases flu) in adults admitted to the hospital. It may help doctors better understand and manage these complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently admitted to the hospital for COVID-19 symptoms, or you found out you have COVID-19 while admitted for something else.
- If it’s COVID, your COVID test (PCR or antigen) was positive within 4 weeks of your hospital admission.
- If it’s flu, you have a positive flu A or B test within 4 weeks, and a negative COVID test.
- You are not pregnant.
- You do not have a bleeding disorder, and you do not have active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often blood clot–related problems happen in people hospitalized with serious COVID-19 lung illness. It may help doctors understand risks and improve care for patients in the hospital.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
This study follows adults who are in the hospital (including the emergency ward) with a confirmed COVID-19 infection. It aims to learn how COVID-19 affects people in the hospital and how different cases may differ over time.
This study tracks bleeding, clotting problems, and blood transfusion needs in ICU patients with COVID-19 who are on a special heart-lung machine called V-V ECMO. It helps doctors understand how to better care for these very ill patients.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.